Monitoring Glioblastoma Extracellular Vesicle Evolution Using a Nanodiagnostic Platform to Detect Glioma Stem Cells Driving Recurrent Disease

To address the need for monitoring tumor evolution and therapeutic resistance, researchers developed a glioblastoma (GBM) biomarker panel for multiplexed profiling of small extracellular vesicles using an advanced GBM Extracellular Vesicle Monitoring Phenotypic Analyzer Chip.